MannKind CorporationCompany Review & Valuation

MNKD
Nasdaq
Latest Price
2.00USD
Market Capitalization
424.59mUSD

About MannKind Corporation

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients. It offers Afrezza, a dry powder formulation of human insulin that controls high blood sugar in adults with tyShow morepe 1 and type 2 diabetes in the United States. The company has a licensing and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California.Show less

Industry
Biotechnology
HQ Location
Westlake Village, California

Stock Price

Price data not available for MannKind Corporation.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Biogen
Basilea Pharmaceutica
BioTime
Kalytera Therapeutics

back to top